To Evaluate the effect of Vachaharidradi Ghana Vati in the management of High Cholesterol

A Randomized Controlled Clinical Trial to evaluate the effect of Vachaharidradi Ghana Vati in the management of Dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073699

Enrollment

Registered

2024-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: subjects between age of 18 to 64 years of age. Patients Fulfilling the diagnostic and pre diagnosed patients with dyslipidemic range total cholestrol 200 to 239 mg per dl LDL 129 to 159 mg per dl Triglyceride 150 to 199 mg per dl HDL less than 40 mg per dl QRISK Value less than 10 percentage

Exclusion criteria

Exclusion criteria: known case of primary dyslipidemia, coronary artery disease, cerebrovascular accident, peripheral artery disease carcinomas renal disorders like chronic kidney disease and nephrotic syndrome hepatic disorders like liver cirrhosis, steatotic liver disease, hypothyroidism, hypertension, diabetes mellitus Dyslipidemia due to consumption of drugs like glucocorticoids and diuretics pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Reduction in Lipid ProfileTimepoint: 31 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K R Sreeranjani

Sri Jayendra Saraswathi Ayurveda College and Hospital

drsrout@gmail.com9444881980

Outcome results